EGFR and cancer: In a recent example, Lee et al. prepared water-oil-water double emulsion nanoparticles for the concomitant loading of doxorubicin and erlotinib (hydrophobic), a small-molecule inhibitor of epidermal growth factor receptors (EGFR, dysregulated in several cancer types) [12].